PMV Pharmaceuticals (PMVP) Earnings Analysis

PMV Pharmaceuticals (PMVP) next reports earnings on 2026-08-06, consensus EPS -0.38 USD. Last quarter (2026-03-06) it beat with EPS -0.34 USD vs -0.4 USD est (+15%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -0.89.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PMVP next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate-0.38 USD
Revenue estimaten/a

PMVP earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-06-0.34 USD-0.4 USD+15%Beat
2025-11-12-0.4 USD-0.4 USD0%Beat
2025-08-07-0.41 USD-0.39 USD-5.1%Miss
2025-05-09-0.34 USD-0.37 USD+8.1%Beat
2025-03-03-0.45 USD-0.38 USD-18.4%Miss
2024-08-08-0.02 USD-0.34 USD+94.1%Beat

Beat rate: 4/6 (67%) over reported quarters with consensus data.

PMVP valuation and analyst view

Trailing P/E-0.89
Trailing EPS-1.46899 USD
Price / book0.81
Dividend yield0.00%
Market cap0.07B
Analyst consensusBuy (4 buy / 0 hold / 0 sell)
Avg price target5 USD

Related research pages

Frequently asked questions

When is PMV Pharmaceuticals (PMVP)'s next earnings date?

PMV Pharmaceuticals is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.38 USD.

Did PMVP beat earnings last quarter?

In its 2026-03-06 report, PMVP posted EPS of -0.34 USD versus a -0.4 USD estimate — a beat of 15%.

What is PMVP's earnings track record?

Over the last 6 reported quarters with consensus data, PMVP beat estimates 4 times (67%).

What is PMVP's current P/E ratio and EPS?

PMVP trades at a trailing P/E of -0.89 on trailing EPS of -1.4689931700367844 USD.

What do analysts rate PMVP?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 5 USD.